TAKE 15% OFF SITEWIDE with code: PRIMED

Back to shop
Secretagogue Research

Tesamorelin

Lyophilized • Requires Reconstitution

US$120
Select Vial Size

Tesamorelin, a synthetic analog of growth hormone-releasing hormone (GHRH) supplied as a premium research-grade lyophilized peptide for laboratory research. Tesamorelin has been studied in laboratory and preclinical research involving growth hormone secretion, insulin-like growth factor-1 (IGF-1) biology, pituitary physiology, endocrine regulation, and metabolic pathways. It remains a peptide of interest in peptide science, endocrinology, and metabolic research.

Product Specifications

  • Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
  • Molecular Weight: 5135.9 g/mol
  • Type: Synthetic GHRH Analog Peptide
  • CAS Number: 901758-09-6
  • Appearance: White Lyophilized Powder
  • Purity: ≥99% (HPLC)

Storage Requirements

  • Lyophilized Product: Store at -20°C. Protect from moisture and light. Shelf Life: ≥12 months.
  • Reconstituted Product: Store refrigerated at 2-8°C. Stability: 1-4 weeks.

Important Research Notice

Research use only. Not for human or veterinary consumption. This product is intended solely for laboratory research and educational applications. It is not designed for use in the diagnosis, treatment, cure, or prevention of any disease or medical condition. The research references provided below are derived from publicly available scientific literature, including peer-reviewed journals and official scientific publications where applicable. They are provided solely for educational and informational purposes and should not be interpreted as medical advice or as claims regarding the safety, efficacy, or intended use of this product. By purchasing this product, you acknowledge that this product is intended for research use only and agree to use it in accordance with all applicable laws and regulations.

References

  1. Tesamorelin - Peptide Center guide
  2. Tesamorelin2012
  3. TesamorelinNature reviews. Drug discovery, 2011
  4. Efficacy and safety of tesamorelin in people with HIV on integrase inhibitorsAIDS (London, England), 2024
  5. Tesamorelin updateBETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 2010
  6. Tesamorelin: a review of its use in the management of HIV-associated lipodystrophyDrugs, 2011
  7. Effects of Tesamorelin on Neurocognitive Impairment in Persons With HIV and Abdominal ObesityThe Journal of infectious diseases, 2025